Cost, Value and Access of Personalized Medicine

Linda D. Bosserman, MD, FACP

Video Categories: Value

Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access
July 25, 2018

What the Next Generation of Cancer Biomarkers May Involve

Dr Sanjiv Agarwala predicts that the cancer biomarkers of the future may be “mobile biomarkers,” meaning measures of the tumor microenvironment or immune response that change with therapy and may be able to determine treatment efficacy.

October 7, 2016

Tailoring Treatment Regimens for Patients with HR+/HER2-Negative Metastatic Breast Cancer

Dr Sunil Verma identifies how he makes treatment decisions for his patients, noting that he tends to use endocrine treatments instead of chemotherapy.